Jose Luis Vazquez Martinez
- Ter, 12/10/2021 - 15:48
Source: Frost, M.C., Lampert, H., Tsui, J.I. et al. The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review. Addict Sci Clin Pract 16, 62 (2021). https://doi.org/10.1186/s13722-021-00266-2 Abstract Background Methamphetamine...
Shared by Joanna
(ISSUP staff) - Sex, 01/10/2021 - 16:57
The abstract submission deadline EXTENDED! Abstract submissions for our event taking place online and in person in Abu Dhabi: 11-16th May, 2022 has been extended to 31st October! Find out more about the event and submit your abstract: issup.net/event2022
Shared by James Harvey
(ISSUP staff) - Qui, 09/09/2021 - 09:55
ICUDDR, INL, ISSUP and NRC are partnering to host a global in person and online event from 11th – 16th May 2022 in Abu Dhabi, UAE. We welcome abstract submissions for sub-plenary and poster presentations at the event. DEADLINE EXTENDED!
Jose Luis Vazquez Martinez
- Sex, 20/08/2021 - 15:16
Fuente: Abellón-Ruiz, J. (2021). Procedimiento para la detección y abordaje de la adicción en pacientes en tratamiento con opioides de prescripción médica. Desde el Ministerio de Sanidad de Murcia, España, se ha puesto en marcha un grupo de trabajo para la elaboración del “Plan de optimización de la...
Shared by Rasha Abi Hana
- Sex, 20/08/2021 - 15:03
Format
Scientific article
Published by / Citation
Daniel Wolfe, Roxanne Saucier, Reprint of: Biotechnologies and the future of opioid addiction treatments, International Journal of Drug Policy, Volume 94, 2021, 103273, ISSN 0955-3959, https://doi.org/10.1016/j.drugpo.2021.103273.
Biotechnological treatment, including addiction treatment, is the way of the future. Researchers and pharmaceutical companies praise depot injections, agonist/antagonist implants, deep brain stimulation, and hapten conjugate vaccines as medicine's greatest chance for reducing illegal usage, reducing the danger of overdose and severe withdrawal, and preventing drug diversion to criminal markets.
Old conflicts around ideas of addiction and treatment are revealed by marketing and the use of new technologies: between medical condition and will disorder, between criminal justice and health, and...
Overdose is the leading cause of avoidable death among people who inject drugs.
The ‘Stop Overdose Safely’is a joint initiative from UNODC and the World Health Organization (WHO) to address opioid overdose and provide life-saving medications to those in need. The initiative serves as a platform for exchange and mutual support to effectively prevent and manage overdose.
The S-O-S initiative supports people likely to witness an overdose in the community, with a focus on people who use drugs, their peers, as well as family members.
The initiative sets a global implementation target of...
Worldwide, about 500 000 deaths are attributable to drug use. More than 70% of these deaths are related to opioids, with more than 30% of those deaths caused by overdose.
This information page, put together by the World Health Organisation, provides key facts on opioid overdose.
Agnoli A, Xing G, Tancredi DJ, Magnan E, Jerant A, Fenton JJ. Association of Dose Tapering With Overdose or Mental Health Crisis Among Patients Prescribed Long-term Opioids. JAMA. 2021;326(5):411–419. doi:10.1001/jama.2021.11013
In response to the concerning numbers of opioid-related deaths in the US, there has been a recent focus on opioid prescribing trends, which has shown an increase in opioid tapering among patients prescribed long-term opioid therapy. However, there has also been an increase in opioid-related mortality.
This article examines the relationship between opioid dose tapering among patients prescribed stable, long-term, higher-dose opioids and rates of overdose and mental health crisis.
On examination of 114,000 patients who had been prescribed "stable, high doses of opioids", the researchers...
Background: Some countries have used opioid agonist medications other than methadone and buprenorphine as a strategy to increase treatment diversity. In Iran and other countries where opium use is common and culturally tolerated, opium tincture (OT) has gained growing popularity and been approved to treat opioid use disorder (OUD). Given the increasing interest in this intervention, we conducted a systematic review of the literature to evaluate the safety and efficacy of OT-assisted treatment for OUD.
Methods: We systematically searched international (MEDLINE, Embase, CINAHL...
Shared by Rasha Abi Hana
- Qui, 22/07/2021 - 11:07
Format
Scientific article
Published by / Citation
Guerrero, E., Amaro, H., Kong, Y. et al. Gender disparities in opioid treatment progress in methadone versus counseling. Subst Abuse Treat Prev Policy 16, 52 (2021). https://doi.org/10.1186/s13011-021-00389-4
The high dropout rate (75%) in opioid use disorder (OUD) treatment among women and racial/ethnic minorities in the United States necessitates a better knowledge of the factors that contribute to treatment success. While therapy and medication for OUD are considered the top standard of care in substance use disorder (SUD) treatment, many people with OUD receive just counseling or methadone-only therapies. This study compares gender inequalities in methadone-based treatment plan progress to counseling-based programs in one of the biggest SUD treatment systems in the United States.
Shared by Rasha Abi Hana
- Qui, 22/07/2021 - 10:55
Format
Scientific article
Published by / Citation
Herring AA, Vosooghi AA, Luftig J, et al. High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder. JAMA Netw Open. 2021;4(7):e2117128. doi:10.1001/jamanetworkopen.2021.17128
In response to the rising efficacy of the illicit opioid drug supply and often observed delays in access to follow-up therapy, emergency departments (EDs) occasionally utilize a high-dose buprenorphine induction method for the treatment of opioid use disorder (OUD). The objective of this study is to investigate the safety and tolerability of high-dose (>12 mg) buprenorphine induction for patients with OUD presenting to an ED.
Data were manually extracted from electronic health records for all ED patients with OUD treated with buprenorphine at a single, urban, safety-net hospital in Oakland...
Jose Luis Vazquez Martinez
- Sex, 16/07/2021 - 20:49
Source: Herring AA, Vosooghi AA, Luftig J, et al. High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder. JAMA Netw Open. 2021;4(7):e2117128. doi:10.1001/jamanetworkopen.2021.17128 Key Points Question Is high-dose (>12 mg) buprenorphine induction safe and...
Carlyle, M., Broomby, R., Simpson, G., Hannon, R., Fawaz, L., Mollaahmetoglu, O. M., ... & Morgan, C. J. (2021). A randomised, double‐blind study investigating the relationship between early childhood trauma and the rewarding effects of morphine. Addiction Biology, e13047.
Research from the University of Exeter has highlighted how childhood trauma can make individuals more sensitive to the pleasurable and motivational effects of opioids and less sensitive to the negative consequence of the drugs.
The research, which has been published in the journal of Addiction Biology, aimed to assess the impact of childhood trauma on responses to morphine and pain processing.
As part of a randomised control trial, 52 healthy people- 27 with a history of childhood abuse and neglect, and 25 who reported no such experiences in childhood- received either an active dose of...
Jose Luis Vazquez Martinez
- Qua, 30/06/2021 - 21:45
Source: Hser, YI., Ober, A.J., Dopp, A.R. et al. Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial. Addict Sci Clin Pract 16, 24 (2021)...
Marshall, K., Maina, G. & Sherstobitoff, J. Plausibility of patient-centred care in high-intensity methadone treatment: reflections of providers and patients. Addict Sci Clin Pract 16, 42 (2021). https://doi.org/10.1186/s13722-021-00251-9
Abstract
Background: Patients with opioid use disorder (OUD) often have complex health care needs. Methadone is one of the medications for opioid use disorder (MOUD) used in the management of OUDs. Highly restrictive methadone treatment—which requires patient compliance with many rules of care—often results in low retention, especially if there is inadequate support from healthcare providers (HCPs). Nevertheless, HCPs should strive to offer patient-centred care (PCC) as it is deemed the gold standard to care. Such an approach can encourage patients to be actively involved in their care...
Jose Luis Vazquez Martinez
- Qua, 30/06/2021 - 14:32
Source: Marshall, K., Maina, G. & Sherstobitoff, J. Plausibility of patient-centred care in high-intensity methadone treatment: reflections of providers and patients. Addict Sci Clin Pract 16, 42 (2021). https://doi.org/10.1186/s13722-021-00251-9 Abstract Background Patients with opioid use disorder...
Jose Luis Vazquez Martinez
- Qua, 30/06/2021 - 05:39
Source: Kelley, A.T., Smid, M.C., Baylis, J.D. et al. Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities. Addict Sci Clin Pract 16, 40 (2021). https://doi.org/10.1186/s13722-021-00246-6 Abstract...